CAR and PXR agonists stimulate hepatic bile acid and bilirubin detoxification and elimination pathways in mice†

Wagner, Martin, Halilbasic, Emina, Marschall, Hanns‐Ulrich, Zollner, Gernot, Fickert, Peter, Langner, Cord, Zatloukal, Kurt, Denk, Helmut, Trauner, Michael·2005·Hepatology
DOI 10.1002/hep.20784

Cited by (352)

Items 101–200 of 352

  1. Master regulation of bile acid and xenobiotic metabolism via the FXR, PXR and CAR trio
    Salvatore Modica · 2009 · Frontiers in bioscience
  2. Clinical application of transcriptional activators of bile salt transporters
    Anna Baghdasaryan, Peter Chiba, Michael Trauner · 2013 · Molecular Aspects of Medicine
  3. Nuclear Receptor Metabolism of Bile Acids and Xenobiotics: A Coordinated Detoxification System with Impact on Health and Diseases
    Manon Garcia, Laura Thirouard, Lauriane Sèdes, Mélusine Monrose, Hélène Holota, Françoise Caira, David H. Volle, Claude Beaudoin · 2018 · International Journal of Molecular Sciences
  4. Gut microbiota in regulatory T cell generation and function: mechanisms and health implications
    Amit Sharma, Garima Sharma, Sin‐Hyeog Im · 2025 · Gut Microbes
  5. Lignans from Schisandra sphenanthera protect against lithocholic acid-induced cholestasis by pregnane X receptor activation in mice
    Shicheng Fan, Conghui Liu, Yiming Jiang, Yue Gao, Yixin Chen, Kaili Fu, Xinpeng Yao, Min Huang, Huichang Bi · 2019 · Journal of Ethnopharmacology
  6. Pregnane-x-receptor controls hepatic glucuronidation during pregnancy and neonatal development in humanized UGT1 mice
    Shujuan Chen, Mei‐Fei Yueh, Ronald M. Evans, Robert H. Tukey · 2012 · Hepatology
  7. Statin Regulation of CYP3A4 and CYP3A5 Expression
    Maria Alice V. Willrich, Mário Hiroyuki Hirata, Rosário Dominguez Crespo Hirata · 2009 · Pharmacogenomics
  8. Clinical Chemistry of the Laboratory Mouse
    F WQUIMBY, R HLUONG · 2007 · Elsevier eBooks
  9. Mesenchymal stem cell-derived exosome mitigates colitis via the modulation of the gut metagenomics–metabolomics–farnesoid X receptor axis
    Dickson Kofi Wiredu Ocansey, Zhiyu Zhang, Xinwei Xu, Lianqin Liu, Samuel Amoah, Xiang Chen, Bo Wang, Xu Zhang, Fei Mao · 2022 · Biomaterials Science
  10. Mechanisms of hepatic and renal injury in lipid metabolism disorders in metabolic syndrome
    Jin Rong, Zixuan Zhang, Xiaoyu Peng, Ping Li, Tingting Zhao, Yifei Zhong · 2024 · International Journal of Biological Sciences
  11. Constitutive androstane receptor activation stimulates faecal bile acid excretion and reverse cholesterol transport in mice
    Anne-Laure Sberna, Mahfoud Assem, Thomas Gautier, Jacques Grober, Boris Guiu, Aline Jeannin, Jean-Paul Paı̈s de Barros, Anne Athias, Laurent Lagrost, David Masson · 2010 · Journal of Hepatology
  12. Changes of Organic Anion Transporter MRP4 and Related Nuclear Receptors in Human Obstructive Cholestasis
    Jin Chai, Donglin Luo, Xiaoping Wu, Huaizhi Wang, Yu He, Qiong Li, Yanmei Zhang, Lei Chen, Zhihong Peng, Tianli Xiao et al. · 2011 · Journal of Gastrointestinal Surgery
  13. Hepatocellular transport in acquired cholestasis: new insights into functional, regulatory and therapeutic aspects
    Marcelo G. Roma, Fernando Ariel Crocenzi, Enrique Juan Sánchez Pozzi · 2008 · Clinical Science
  14. Farnesoid X receptor agonists for primary biliary cirrhosis
    Keith D. Lindor · 2011 · Current Opinion in Gastroenterology
  15. New in Vitro Tools to Study Human Constitutive Androstane Receptor (CAR) Biology: Discovery and Comparison of Human CAR Inverse Agonists
    Jenni Küblbeck, Johanna Jyrkkärinne, Ferdinand Molnár, Tiina Kuningas, Jayendra Z. Patel, Björn Windshügel, Tapio Nevalainen, Tuomo Laitinen, Wolfgang Sippl, Antti Poso et al. · 2011 · Molecular Pharmaceutics
  16. Prediction of drug-induced liver injury and cardiotoxicity using chemical structure and in vitro assay data
    Lin Ye, Deborah K. Ngan, Tuan Xu, Zhichao Liu, Jinghua Zhao, Srilatha Sakamuru, Li Zhang, Tongan Zhao, Menghang Xia, Anton M. Simeonov et al. · 2022 · Toxicology and Applied Pharmacology
  17. In Vivo Responses of the Human and Murine Pregnane X Receptor to Dexamethasone in Mice
    Nico Scheer, Jillian Ross, Yury Kapelyukh, Anja Rode, C. Roland Wolf · 2010 · Drug Metabolism and Disposition
  18. The history and future of bile acid therapies
    Ulrich H. Beuers, Jesús M. Bañales, Saul J. Karpen, Verena Keitel, Catherine Williamson, Michael Trauner · 2025 · Journal of Hepatology
  19. Hepatic Expression of Detoxification Enzymes Is Decreased in Human Obstructive Cholestasis Due to Gallstone Biliary Obstruction
    Jin Chai, Xinchan Feng, Liangjun Zhang, Sheng Chen, Ying Cheng, Xiaochong He, Yingxue Yang, Yu He, Huaizhi Wang, Rongquan Wang et al. · 2015 · PLoS ONE
  20. Effects of statins on the chemoresistance—The antagonistic drug-drug interactions versus the anti-cancer effects
    Yasin Ahmadi, Ramin Karimian, Yunes Panahi · 2018 · Biomedicine & Pharmacotherapy
  21. The role of circadian rhythm in choroid plexus functions
    Telma Quintela, André Furtado, Ana Catarina Duarte, Isabel Gonçalves, Jihwan Myung, Cecília R.A. Santos · 2021 · Progress in Neurobiology
  22. Cholestasis and cholestatic syndromes
    Jacqueline G OʼLeary, Daniel Stephan Pratt · 2007 · Current Opinion in Gastroenterology
  23. The Multifaceted Role of Bilirubin in Liver Disease: A Literature Review
    Mariana Michelle Ramírez-Mejía, Stephany M. Castillo-Castañeda, Shreya C. Pal, Xingshun Qi, Nahúm Méndez‐Sánchez · 2024 · Journal of Clinical and Translational Hepatology
  24. Nuclear Receptors CAR and PXR; therapeutic targets for cholestatic liver disease
    Satoru Kakizaki · 2011 · Frontiers in bioscience
  25. Augmented particle trapping and attenuated inflammation in the liver by protective vaccination against Plasmodium chabaudi malaria
    Jürgen Krücken, Denis Delić, Heike Pauen, Anna Wojtalla, Manal F. El‐Khadragy, Mohamed A. Dkhil, Horst Mossmann, Frank Thomas Wunderlich · 2009 · Malaria Journal
  26. PXR agonism decreases plasma HDL levels in ApoE⁎3-Leiden.CETP mice
    Willeke de Haan, Jitske de Vries-van der Weij, Isabel M. Mol, Menno Hoekstra, Johannes Anthonius Romijn, J. Wouter Jukema, Louis M. Havekes, Hans M. G. Princen, Patrick C.N. Rensen · 2008 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
  27. Redox‐Dependent Effects in the Physiopathological Role of Bile Acids
    Josué Orozco-Aguilar, Felipe Simón, Claudio Cabello‐Verrugio · 2021 · Oxidative Medicine and Cellular Longevity
  28. Metabolism-Disrupting Chemicals Affecting the Liver: Screening, Testing, and Molecular Pathway Identification
    Kristin Fritsche, Andrea Ziková, Philip Marx‐Stoelting, Albert Braeuning · 2023 · International Journal of Molecular Sciences
  29. Interactions of pesticides with membrane drug transporters: implications for toxicokinetics and toxicity
    Lisa Chedik, Arnaud Bruyère, Astrid Bacle, Sophie Potin, Marc Le Vée, Olivier Fardel · 2018 · Expert Opinion on Drug Metabolism & Toxicology
  30. Bile Acids, Nuclear Receptors and Cytochrome P450
    Jan Juřica, Gabriela Dovrtělová, Kristýna Nosková, Ondřej Zendulka · 2016 · Physiological Research
  31. Species-specific regulation of PXR/CAR/ER-target genes in the mouse and rat liver elicited by o, p'-DDT
    Naoki Kiyosawa, Joshua C. Kwekel, Lyle D. Burgoon, Edward Dere, Kurt J. Williams, Colleen H. M. Tashiro, Brock G. Chittim, Timothy Richard Zacharewski · 2008 · BMC Genomics
  32. Activation of Constitutive Androstane Receptor Prevents Cholesterol Gallstone Formation
    Shihai Cheng, Min Zou, Qinhui Liu, Jiangying Kuang, Jing Shen, Shiyun Pu, Lei Chen, Hong Li, Tong Wu, Rui Li et al. · 2017 · American Journal Of Pathology
  33. Deficiency of Capicua disrupts bile acid homeostasis
    Eunjeong Kim, Sung-Jun Park, Nahyun Choi, Jieon Lee, Jeehyun Yoe, Soeun Kim, Hoe‐Yune Jung, Kyong‐Tai Kim, Hyojin Kang, John Denis Fryer et al. · 2015 · Scientific Reports
  34. Legacy and alternative per- and polyfluoroalkyl substances (PFAS) alter the lipid profile of HepaRG cells
    Lackson Kashobwe, Faezeh Sadrabadi, Lars Brunken, Ana Carolina M. F. Coêlho, Torkjel Manning Sandanger, Albert Braeuning, Thorsten Buhrke, Mattias Öberg, Timo Hamers, P.E.G. Leonards · 2024 · Toxicology
  35. Constitutive androstane receptor (CAR) is a xenosensor and target for therapy
    Ekaterina Kachaylo, Vladimir O. Pustylnyak, V. V. Lyakhovich, Lyudmila F Gulyaeva · 2011 · Biochemistry (Moscow)
  36. Role of Peroxisome Proliferator-activated Receptor-α in Hepatobiliary Injury Induced by Ammonium Perfluorooctanoate in Mouse Liver
    Mutsuko Minata, Kouji H. Harada, Anna Kärrman, Toshiaki Hitomi, Michi Hirosawa, Mariko Murata, Frank J. Gonzalez, Akio Koizumi · 2010 · Industrial Health
  37. Constitutive Androstane Receptor Activation Decreases Plasma Apolipoprotein B–Containing Lipoproteins and Atherosclerosis in Low-Density Lipoprotein Receptor–Deficient Mice
    Anne-Laure Sberna, Mahfoud Assem, Rui Xiao, Steve Ayers, Thomas Gautier, Boris Guiu, Valérie Deckert, Angélique Chevriaux, Jacques Grober, Naïg Le Guern et al. · 2011 · Arteriosclerosis Thrombosis and Vascular Biology
  38. Dysregulated Bile Acid Synthesis, Metabolism and Excretion in a High Fat-Cholesterol Diet-Induced Fibrotic Steatohepatitis in Rats
    Xiaofang Jia, Hisao Naito, Husna Yetti, Hazuki Tamada, Kazuya Kitamori, Yumi Hayashi, Dong Wang, Yukie Yanagiba, Juncai Wang, Katsumi Ikeda et al. · 2013 · Digestive Diseases and Sciences
  39. Constitutive Androstane Receptor (CAR) as a Potential Sensing Biomarker of Persistent Organic Pollutants (POPs) in Aquatic Mammal: Molecular Characterization, Expression Level, and Ligand Profiling in Baikal Seal (Pusa sibirica)
    Hiroki Sakai, Hisato Iwata, Eun‐Young Kim, Oyuna V. Tsydenova, Nobuyuki Miyazaki, Е. А. Петров, Valeriy B. Batoev, Shinsuke Tanabe · 2006 · Toxicological Sciences
  40. Bile Formation and the Enterohepatic Circulation
    Paul A. Dawson · 2012 · Elsevier eBooks
  41. Insights into Ligand-Elicited Activation of Human Constitutive Androstane Receptor Based on Novel Agonists and Three-Dimensional Quantitative Structure−Activity Relationship
    Johanna Jyrkkärinne, Björn Windshügel, Toni P. Ronkko, Anu J. Tervo, Jenni Küblbeck, Maija K. Lahtela-Kakkonen, Wolfgang Sippl, Antti Poso, Paavo Honkakoski · 2008 · Journal of Medicinal Chemistry
  42. Protective Functions of ZO-2/Tjp2 Expressed in Hepatocytes and Cholangiocytes Against Liver Injury and Cholestasis
    Jianliang Xu, P. Jaya Kausalya, Noémi Van Hul, Matias J. Caldez, Shiyi Xu, Alicia Ghia Min Ong, Wan Lu Woo, Safiah Mohamed Ali, Philipp Kaldis, Walter Hunziker · 2021 · Gastroenterology
  43. Oral administration of oleanolic acid, isolated from Swertia mussotii Franch, attenuates liver injury, inflammation, and cholestasis in bile duct-ligated rats.
    Jin Chai, Xiaohuang Du, Sheng Chen, Xinchan Feng, Ying Cheng, Liangjun Zhang, Yu Gao, Shaoxue Li, Xiaochong He, Rongquan Wang et al. · 2015 · PubMed Central
  44. Increased sulfation of bile acids in mice and human subjects with sodium taurocholate cotransporting polypeptide deficiency
    Fengfeng Mao, Teng Liu, Xinfeng Hou, Hanqing Zhao, Wenhui He, Cong Li, Zhiyi Jing, Jianhua Sui, Fengchao Wang, Xiaohui Liu et al. · 2019 · Journal of Biological Chemistry
  45. A translational view on the biliary lipid secretory network
    Giuseppe Lo Sasso, Michele Petruzzelli, Antonio Moschetta · 2007 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
  46. Nuclear Receptors in Acute and Chronic Cholestasis
    Ester Gonzalez‐Sanchez, Delphine Firrincieli, Chantal Housset, Nicolas Chignard · 2015 · Digestive Diseases
  47. Evaluation of transcriptomic signature as a valuable tool to study drug-induced cholestasis in primary human hepatocytes
    Celine Parmentier, Philippe Couttet, Armin Wolf, Thomas Zaccharias, Bruno Heyd, Philippe Bachellier, Marianne Uteng, Lysiane Richert · 2017 · Archives of Toxicology
  48. Tanshinone IIA prevents rifampicin‐induced liver injury by regulating BSEP/NTCP expression via epigenetic activation of NRF2
    Yujie Yang, Lei Liu, Xiqian Zhang, Xuehua Jiang, Ling Wang · 2019 · Liver International
  49. Gestational GenX and PFOA exposures induce hepatotoxicity, metabolic pathway, and microbiome shifts in weanling mice
    Qin-Yao Zhang, Lingling Xu, Mei-Ting Zhong, Yu-Kui Chen, Ming-Quan Lai, Qi Wang, Xiao‐Li Xie · 2023 · The Science of The Total Environment
  50. Alteration of Methotrexate Biliary and Renal Elimination during Extrahepatic and Intrahepatic Cholestasis in Rats
    Eva Doleželová, Leoš Fuksa, Jolana Cermanová, Gabriela Kolouchová, Milos Hroch, Petra Hirsova, Jiřina Martı́nková, František Štaud, Stanislav Mičuda · 2009 · Biological and Pharmaceutical Bulletin
  51. Effectiveness of high dose dexamethasone in the treatment of acute stroke.
    Shamsideen Abayomi Ogun, Kayode A. Odusote · 2001 · PubMed
  52. Geniposide Inhibits Alpha-Naphthylisothiocyanate-Induced Intrahepatic Cholestasis: The Downregulation of STAT3 and NFκB Signaling Plays an Important Role
    Zhen Tan, Aiming Liu, Min Luo, Xuan Yin, Danjun Song, Manyun Dai, Pengxu Li, Zanbo Chu, Zuquan Zou, Ming Ma et al. · 2016 · The American Journal of Chinese Medicine
  53. Post-hepatectomy liver regeneration in the context of bile acid homeostasis and the gut-liver signaling axis
    Lianne R. de Haan, Sarah J van der Lely, Anne‐Loes K. Warps, Quincy Hofsink, Pim B. Olthof, Mark J. de Keijzer, Daniël A. Lionarons, Lionel Mendes Dias, Bote G. Bruinsma, Korkut Uygun et al. · 2018 · Journal of Clinical and Translational Research
  54. Molecular bases of the fetal liver–placenta–maternal liver excretory pathway for cholephilic compounds
    José J.G. Marı́n, Rocı́o I.R. Macı́as, Óscar Briz, María J. Perez, Alba G. Blazquez, Marco A. Arrese, Maria Angeles Serrano · 2008 · Liver International
  55. Novel therapeutics for primary biliary cholangitis: Toward a disease-stage-based approach
    Hani S. Mousa, Marco Carbone, Federica Malinverno, Vincenzo Ronca, Merrill Eric Gershwin, Pietro Invernizzi · 2016 · Autoimmunity Reviews
  56. Contribution of the microbiome for better phenotyping of people living with obesity
    Agostino Di Ciaula, Leonilde Bonfrate, Mohamad Khalil, Gabriella Garruti, Piero Portincasa · 2023 · Reviews in Endocrine and Metabolic Disorders
  57. Pharmacological Therapies for Unconjugated Hyperbilirubinemia
    Frans J.C. Cuperus, Anja M. Hafkamp, Christian Victor Hulzebos, Henkjan J. Verkade · 2009 · Current Pharmaceutical Design
  58. Regulation of the expression of renal drug transporters in KEAP1-knockdown human tubular cells
    Hyuk-Sang Jeong, In-geun Ryoo, Mi‐Kyoung Kwak · 2015 · Toxicology in Vitro
  59. Xanthohumol ameliorates Diet-Induced Liver Dysfunction via Farnesoid X Receptor-Dependent and Independent Signaling
    Ines L. Paraiso, Thai Q. Tran, Armando Alcázar Magaña, Payel Kundu, Jaewoo Choi, Claudia S. Maier, Gerd Bobe, Jacob Raber, Chrissa Kioussi, Jan Frederik Stevens · 2021 · Frontiers in Pharmacology
  60. The Role of Vitamin K in Cholestatic Liver Disease
    Halima Sultana, Michio Komai, Hitoshi Shirakawa · 2021 · Nutrients
  61. Medical Treatment of Primary Sclerosing Cholangitis: A Role for Novel Bile Acids and other (post-)Transcriptional Modulators?
    Ulrich H. Beuers, Gerd Achim Kullak-Ublick, Thomas Pusl, Erik A. Rauws, Christian Rust · 2008 · Clinical Reviews in Allergy & Immunology
  62. Current strategies for managing intestinal failure-associated liver disease
    Jordan D. Secor, Lumeng Jenny Yu, Savas T. Tsikis, Scott C. Fligor, Mark Puder, Kathleen M. Gura · 2020 · Expert Opinion on Drug Safety
  63. Bile acid conjugation deficiency causes hypercholanemia, hyperphagia, islet dysfunction, and gut dysbiosis in mice
    Bandar D. Alrehaili, Mikang Lee, Shogo Takahashi, Robert W. Novak, Bipin Rimal, Shannon Boehme, Samuel A.J. Trammell, Trisha Jean Grevengoed, Devendra Kumar, Yazen Alnouti et al. · 2022 · Hepatology Communications
  64. Bacterial-dependent up-regulation of intestinal bile acid binding protein and transport is FXR-mediated following ileo-cecal resection
    Christopher M. Dekaney, Douglas C. von Allmen, Aaron P. Garrison, Rachael Jane Rigby, P. Kay Lund, Susan Henning, Michael A. Helmrath · 2008 · Surgery
  65. Significance of the Vitamin D Receptor on Crosstalk with Nuclear Receptors and Regulation of Enzymes and Transporters
    Keumhan Noh, Edwin C.Y. Chow, Holly P. Quach, Geny M. M. Groothuis, Rommel G. Tirona, K. Sandy Pang · 2022 · The AAPS Journal
  66. Aryl hydrocarbon receptor ligand 2,3,7,8-tetrachlorodibenzo-p-dioxin enhances liver damage in bile duct-ligated mice
    Jun Ozeki, Shigeyuki Uno, Michitaka Ogura, Mihwa Choi, Tetsuyo Maeda, Kenichi Sakurai, Sadanori Matsuo, Sadao Amano, Daniel W. Nebert, Makoto Makishima · 2010 · Toxicology
  67. Nuclear hormone receptor-dependent regulation of hepatic transporters and their role in the adaptive response in cholestasis
    Simone H. Stahl, Mark R. Davies, David I. Cook, M. J. Graham · 2008 · Xenobiotica
  68. The new therapeutic frontier--nuclear receptors and the liver
    Karpen, Saul J., Trauner, Michael · 2010 · Journal of Hepatology
  69. Pregnane X receptor-mediated induction of Cyp3a by black cohosh
    Xiaoyan Pang, Jie Cheng, Kristopher W. Krausz, Dean Guo, Frank J. Gonzalez · 2010 · Xenobiotica
  70. Benefits and challenges to therapeutic targeting of bile acid circulation in cholestatic liver disease
    Michael Trauner, Saul J. Karpen, Paul A. Dawson · 2025 · Hepatology
  71. Genetics in primary sclerosing cholangitis
    Trine Folseraas, Espen Melum, André Franke, Tom H. Karlsen · 2011 · Best Practice & Research Clinical Gastroenterology
  72. Advances in drug-induced cholestasis: Clinical perspectives, potential mechanisms and in vitro systems
    María Leonor Fernández-Murga, Petar Petrov, Isabel Conde, José Vicente Castell, M. José Gómez‐Lechón, Ramiro Jover · 2018 · Food and Chemical Toxicology
  73. Constitutive Androstane Receptor Differentially Regulates Bile Acid Homeostasis in Mouse Models of Intrahepatic Cholestasis
    Kim, Kang Ho, Choi, Jong Min, Li, Feng, Dong, Bingning, Wooton‐Kee, Clavia Ruth, Arizpe, Armando, Anakk, Sayeepriyadarshini, Jung, Sung Yun, Hartig, Sean M., Moore, David D. · 2019 · Hepatology Communications
  74. Intestine-specific FXR agonists as potential therapeutic agents for colorectal cancer
    Yiming Yin, Mengge Wang, Wenjie Gu, Lili Chen · 2021 · Biochemical Pharmacology
  75. Regulation of hepatic abcb4 and cyp3a65 gene expression and multidrug/multixenobiotic resistance (MDR/MXR) functional activity in the model teleost, Danio rerio (zebrafish)
    Jeremy S. H. Jackson, Christopher J. Kennedy · 2017 · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology
  76. Translational Regulation of Rat Multidrug Resistance-Associated Protein 2 Expression Is Mediated by Upstream Open Reading Frames in the 5′ Untranslated Region
    Yuanyuan Zhang, Wěi Li, Mary E. Vore · 2006 · Molecular Pharmacology
  77. Clinical Hepatotoxicity. Regulation and Treatment with Inducers of Transport and Cofactors
    Hanns–Ulrich Marschall, Martin Wagner, Gernot Zollner, Michael Trauner · 2007 · Molecular Pharmaceutics
  78. Expression Patterns of Organic Anion Transporting Polypeptides 1B1 and 1B3 Protein in Human Pediatric Liver
    Margaret Thomson, Ronald N. Hines, Erin G. Schuetz, Bernd Meibohm · 2016 · Drug Metabolism and Disposition
  79. Activation of Constitutive Androstane Receptor (CAR) in mice results in maintained biliary excretion of bile acids despite a marked decrease of bile acids in liver
    Lickteig, Andrew J., Csanaky, Iván L., Pratt-Hyatt, Matthew, Klaassen, Curtis D. · 2016 · Toxicological Sciences
  80. Bile acids and their receptors in hepatic immunity
    Stefano Fiorucci, Silvia Marchianò, Eleonora Distrutti, Michele Biagioli · 2025 · Liver Research
  81. Helicobacter hepaticus –Induced Liver Tumor Promotion Is Associated with Increased Serum Bile Acid and a Persistent Microbial-Induced Immune Response
    Alexis García, Yu Zeng, Sureshkumar Muthupalani, Zhongming Ge, Amanda F. Potter, Melissa W. Mobley, Chakib Boussahmain, Yan Feng, John S. Wishnok, James G. Fox · 2011 · Cancer Research
  82. Vitamin K1 (Phylloquinone) or Vitamin K2 (Menaquinone-4) Induces Intestinal Alkaline Phosphatase Gene Expression
    Mayu Haraikawa, Natsuko Sogabe, Rieko Tanabe, Takayuki Hosoi, Masae Goseki‐Sone · 2011 · Journal of Nutritional Science and Vitaminology
  83. Dual action of peroxisome proliferator-activated receptor alpha in perfluorodecanoic acid-induced hepatotoxicity
    Min Luo, Zhen Tan, Manyun Dai, Danjun Song, Jiao Lin, Minzhu Xie, Julin Yang, Lu Sun, Dengming Wei, Jinshun Zhao et al. · 2016 · Archives of Toxicology
  84. Atorvastatin up-regulate toxicologically relevant genes in rainbow trout gills
    Kathrin Sabine Ellesat, Tor Fredrik Holth, Marcin Wlodzimierz Wojewodzic, Ketil Hylland · 2012 · Ecotoxicology
  85. Role for enhanced faecal excretion of bile acid in hydroxysteroid sulfotransferase-mediated protection against lithocholic acid-induced liver toxicity
    Masaaki Miyata, Hirotaka Watase, Wataru Hori, Masayuki Shimada, Kiyoshi Nagata, Frank J. Gonzalez, Yasushi Yamazoe · 2006 · Xenobiotica
  86. Pravastatin modulates liver bile acid and cholesterol homeostasis in rats with chronic cholestasis
    Gabriela Kolouchová, Eva Doleželová, Petra Hirsova, Luděk Šišpera, Pavel Tomšík, Jolana Cermanová, Radek Hyšpler, M. Slanařová, Leoš Fuksa, Halka Lotková et al. · 2011 · Journal of Gastroenterology and Hepatology
  87. Bile acid detoxifying enzymes limit susceptibility to liver fibrosis in female SHRSP5/Dmcr rats fed with a high-fat-cholesterol diet
    Husna Yetti, Hisao Naito, Yuan Yuan, Xiaofang Jia, Yumi Hayashi, Hazuki Tamada, Kazuya Kitamori, Katsumi Ikeda, Yukio Yamori, Tamie Nakajima · 2018 · PLoS ONE
  88. Atorvastatin Modulates Bile Acid Homeostasis in Mice with Diet-Induced Nonalcoholic Steatohepatitis
    Hana Laštůvková, Fatemeh Alaei Faradonbeh, Jolana Schreiberová, Milos Hroch, Jaroslav Mokrý, Hana Faistova, Zuzana Nová, Radomı́r Hyšpler, Ivone Cristina Igreja, Petr Nachtigal et al. · 2021 · International Journal of Molecular Sciences
  89. Hepatoprotective Effects of Glycyrrhetinic Acid on Lithocholic Acid-Induced Cholestatic Liver Injury Through Choleretic and Anti-Inflammatory Mechanisms
    Qian Wang, Guochao Song, Fengyi Weng, Bin Zou, Jingyi Jin, Dong-Ming Yan, Bo Tan, Jing Zhao, Yue Li, Furong Qiu · 2022 · Frontiers in Pharmacology
  90. Organic Anion Transporting Polypeptide 1a1 Null Mice Are Sensitive to Cholestatic Liver Injury
    Youcai Zhang, Iván L. Csanaky, Xingguo Cheng, Lois D. Lehman‐McKeeman, Curtis D. Klaassen · 2012 · Toxicological Sciences
  91. p53‐mediated regulation of bile acid disposition attenuates cholic acid‐induced cholestasis in mice
    Pan Chen, Dongshun Li, Yixin Chen, Jiahong Sun, Kaili Fu, Lihuan Guan, Huizhen Zhang, Yiming Jiang, Xi Li, Xuezhen Zeng et al. · 2017 · British Journal of Pharmacology
  92. Editor’s Highlight: Neonatal Activation of the Xenobiotic-Sensors PXR and CAR Results in Acute and Persistent Down-regulation of PPARα-Signaling in Mouse Liver
    Cindy Yanfei Li, Sunny Lihua Cheng, Theo K. Bammler, Julia Yue Cui · 2016 · Toxicological Sciences
  93. Bile Formation and the Enterohepatic Circulation
    Paul A. Dawson, Benjamin L. Shneider, Alan F. Hofmann · 2006 · Elsevier eBooks
  94. Redundant roles for cJun-N-terminal kinase 1 and 2 in interleukin-1β-mediated reduction and modification of murine hepatic nuclear retinoid X receptor α
    Astrid Kosters, Damara White, Hongdan Sun, Sundararajah Thevananther, Saul J. Karpen · 2009 · Journal of Hepatology
  95. Effects of Alterations in CAR on Bilirubin Detoxification in Mouse Collagen-Induced Arthritis
    Atsushi Kawase, You Tsunokuni, Masahiro Iwaki · 2006 · Drug Metabolism and Disposition
  96. Role of the constitutive androstane receptor (CAR) in human liver cancer
    Sarah Da Won Bae, Romario Nguyen, Liang Qiao, Jacob George · 2021 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  97. Cholestasis and cholestatic syndromes
    Anna Rutherford, Daniel Stephan Pratt · 2006 · Current Opinion in Gastroenterology
  98. Enzymatically modified isoquercitrin promotes energy metabolism through activating AMPKα in male C57BL/6 mice
    Hao Jiang, Yasukiyo Yoshioka, Sihao Yuan, Yuko Horiuchi, Yoko Yamashita, Kevin D. Croft, Hitoshi Ashida · 2019 · Food & Function
  99. Altered expression of MRP2, MRP3 and UGT2B1 in the liver affects the disposition of morphine and its glucuronide conjugate in a rat model of cholestasis
    Yoshitaka Hasegawa, Shuichi Kishimoto, Kazuhiro Takahashi, Nobuo Inotsume, Yoshikazu Takeuchi, Shoji Fukushima · 2009 · Journal of Pharmacy and Pharmacology
  100. Threshold dose of piperonyl butoxide that induces reactive oxygen species-mediated hepatocarcinogenesis in rats
    Masako Muguruma, Masaomi Kawai, Yasuaki Dewa, Jihei Nishimura, Yukie Saegusa, Hironobu Yasuno, Meilan Jin, Sayaka Matsumoto, Masayoshi Takabatake, Katsuhiko Arai et al. · 2008 · Archives of Toxicology